Royal Chemistry India Foundation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-06-2024
- Paid Up Capital ₹ 15.00 K
as on 26-06-2024
- Company Age 16 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -15.60%
(FY 2022)
- Profit -65.35%
(FY 2022)
- Ebitda -54.70%
(FY 2022)
- Net Worth 21.18%
(FY 2022)
- Total Assets -22.86%
(FY 2022)
About Royal Chemistry India Foundation
The Corporate was formerly known as Chaitanya Punarnava Ayurveda Hospital And Research Centre. The Company is engaged in the Education Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 15.00 K , as per Ministry of Corporate Affairs (MCA) records.
Paul Lewis, Stephen Joyce, Ajit Sharma, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110DL2008NPL178618
- Company No.
178618
- Company Classification
Private Not For Profit Company
- Incorporation Date
27 May 2008
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Royal Chemistry India Foundation?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Helen Abrahams  | Director | 25-Nov-2015 | Current |
Ajit Sharma  | Director | 17-Sep-2019 | Current |
| Paul Lewis | Director | 26-Nov-2020 | Current |
| Stephen Joyce | Director | 15-Sep-2017 | Current |
Financial Performance of Royal Chemistry India Foundation.
Royal Chemistry India Foundation, for the financial year ended 2022, experienced significant reduction in revenue, with a 15.6% decrease. The company also saw a substantial fall in profitability, with a 65.35% decrease in profit. The company's net worth Soared by an impressive increase of 21.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Royal Chemistry India Foundation?
In 2020, Royal Chemistry India Foundation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Royal Chemistry India Private LimitedActive 11 years 2 monthsPaul Lewis, Stephen Joyce and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Royal Chemistry India Foundation?
Unlock and access historical data on people associated with Royal Chemistry India Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Royal Chemistry India Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Royal Chemistry India Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
